Warren Watson

Warren Watson

Directeur/Membre du Conseil chez
Cardialen, Inc.
73 ans
Health Technology
Consumer Services
Health Services

Profil

Warren S.
Watson
is currently an Independent Director at Cardialen, Inc., Director-Kinship Program at Greater Minneapolis Council of Churches, Inc., and Director at Bardy Diagnostics, Inc. He previously held positions such as Executive Chairman at Cameron Health, Inc., Director at SurVivaLink Corp., Endocardial Solutions, Inc., and CardioMEMS LLC, Lead Independent Non-Executive Director at Nuwellis, Inc., Director at CloSys Corp., Gillette Children's Specialty Healthcare, NuAx, Inc., Mardil, Inc., Citizens Independent Bank (St. Louis Park, Minnesota), and Excigen, Inc., and Vice President-Research & Development at Medtronic, Inc. and Cardiac Rhythm Management.
Mr. Watson received his undergraduate degree from the University of Minnesota and his graduate degree from the College of Science & Engineering.

Postes actifs de Warren Watson

SociétésPosteDébut
Directeur/Membre du Conseil 01/06/2012
Corporate Officer/Principal -
Directeur/Membre du Conseil 01/11/2017

Anciens postes connus de Warren Watson

SociétésPosteFin
NUWELLIS, INC. Directeur/Membre du Conseil 02/06/2023
Directeur/Membre du Conseil 01/01/2016
Directeur/Membre du Conseil 01/01/2016
Directeur/Membre du Conseil 01/01/2016
Président 01/06/2012
Voir l'expérience en détail de Warren Watson

Formation de Warren Watson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

32

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Consumer Services

Electronic Technology

  1. Bourse
  2. Insiders
  3. Warren Watson
🔇